Boulaire, J., Fotcdar, A. and Fotedar, R. The functions of the cdk-cyclin kinase inhibitor p21 WAF1. Pathol Biol (Paris) 2000; 48: 190-202.
Bours, V., Bentires-Alj, ML, Ilellin, A., Viatour, P., Robę, P., Delhalle, S., Benoit, V. and Merville, M. Nuclear factor-kappaB, cancer, and apoptosis fln Process Citation]. Biochern Pharmacol 2000; 60: 1085-1089.
Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K. and Siebenlist, U.
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B hoinodimers. Celi 1993; 72: 729-739.
Bubb, V., McCance, D.J. and Schlegel, R. DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein. Virology 1988; 163: 243-246.
Buchhop, S., Gibson, M.K., Wang, X.W., Wagner, P., Sturzbecher, H.W. and Harris, C.C. Interaction of p53 with the human Rad51 protein. Nucleic Acids Res 1997; 25: 3868-3874.
Buckbinder, L., Talbott, R., Velasco Miguel, S., Takenaka, I., Faha, B., Seizinger, B.R. and Kley, N. lnduction of the growth inhibitor IGF-binding protein 3 by p53. Naturę 1995; 377: 646-649.
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, J.M., Kinzler, K.W. and Vogelstein, B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497-1501.
Buschmann, T., Potapova, O., Bar-Shira, A., Ivanov, V.N., Fuchs, S.Y., Henderson, S., Fried, V.A., Minamoto, T., Alarcon-Vargas, D., Pincus, M.R., Gaarde, W.A., Holbrook, N.J., Shiloh, Y. and Ronai, Z. Jun NH2-terniinal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol Celi Biol 2001; 21: 2743-2754.
Busse, P.M., Bose, S.K., Jones, R.W. and Tołmach, L.J. The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest. Radiat Res 1978; 76: 292-307.
Butz, K., Whitaker, N., Denk, C., Ullmann, A., Geisen, C. and Hoppe-Seyler, F. lnduction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene 1999; 18: 2381-2386.
Caelles, C., Helmberg, A. and Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes [see comments]. Naturę 1994; 370: 220-223.
Canman, C.E., Lim, D.S., Cimprich, K.A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M.B. and Siliciano, J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281: 1677-1679.
Carillo, S., Pariat, M., Jaricl-Encontre, I., Steff, A.M. and Piechaczyk, M. Le catabolisme protćique intracellulaire. Partie 1 : les mćcanismes de degradation. Mćdecine/Sciences 1995; 11: 723-734.
Ceraline, J., Deplancjue, G., Duclos, B., Limacher, J.M., Hajri, A., Noel, F., Orvain, C., Frebourg, T., Klein-Soyer, C. and Bergerat, J.P. Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents. Int J Cancer 1998; 75: 432-438.
Challberg, M.D. and Kelly, T.J. Animal virus DNA replication. Annu Rev Biochern 1989; 58:671-717.
Chan, T.A., Hwang, P.M., Hermeking, H., Kinzler, K.W. and Vogelstein, B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev 2000; 14: 1584-1588.
Chaturvedi, M.M., Kumar, A., Darnay, B.G., Chainy, G.B., Agarwal, S. and Aggarwal, B.B. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB
167